LaborGesundheitOriginaltext auf Englisch
Two blood proteins linked to future disability in adults 85+
B2M and cystatin C were associated with higher disability risk in 230 disability-free Japanese adults.
Von KI verfasst1 Quelle2 Min.
Loading…
Diagnostik, Prothesen, Impfstoffe, Genomik: die Medizin, die Lebensjahre gewinnt.
Medizin, die Lebensjahre gewinnt: KI-gestützte Vorsorge, die Millionen Patienten untersucht, Impfstoffe der neuen Generation, Genomik auf dem Weg von der Sequenzierung zur Therapie, Prothesen und Implantate, die verlorene Fähigkeiten zurückgeben. Die Rubrik verfolgt abgeschlossene klinische Studien, Marktzulassungen, Einführungen in Kliniken — den Moment, in dem eine Technologie aufhört, ein Paper zu sein, und zur Versorgung wird.
Die Zahlen entscheiden: Kohorten, Erkennungsraten, vermiedene Sterblichkeit, Kosten. Wir berichten gern über Gesundheitssysteme, die im großen Maßstab einführen — Indien, Brasilien, Südostasien —, weil sich sparsame Technologien oft dort bewähren, bevor sie anderswo ankommen. Jeder Artikel stützt sich auf die Studie, die Zulassung oder die Untersuchung dahinter — und nennt sie.
B2M and cystatin C were associated with higher disability risk in 230 disability-free Japanese adults.
The study compared immunotherapy alone with a chemotherapy-immunotherapy combination before surgery.
The Danish study involved 60 adults and used PET/MR imaging to examine dopamine, glucose metabolism and brain communication.
It targets podocytes in the kidney and hepatocytes in the liver, two cell types tied to age-related disease.
The open-source project brings fNIRS and DOT analysis into one Python workflow.
NIH researchers linked the effect to heat, not necessarily the immune response behind a fever.
The analysis covered nine randomized trials involving 1,258 adults with recurrent depression in remission.
An iron supplement raised survival from 50% to 100% in mice with Citrobacter rodentium.
The ACCESS trial studied 268 adults whose donors were mismatched at six of eight key HLA markers.
University of Missouri researchers used Torin 2 to enhance autophagy, the cell’s cleanup and recycling process.
Drexel and UC Davis researchers tested WeCareAdvisor with family caregivers over three months.
Salk researchers linked the attack to TAM proteins, especially Axl and Mer.
The SF-10 checks five social-risk domains in a brief screening tool for older adults.
Celltrion received Japanese approval in April and launched the IV version about four months later.
The hospital says the implant is the world's first personalized bone metamaterial prosthesis.
A UNC-led trial adapted Mediterranean-style eating to foods common in the Southeast.
The remote trial followed 825 adults across 13 countries, with outcomes measured after 12 weeks.
The estimate comes from Sweden’s Stockholm–Gotland program, followed for up to 14 years.